CRP levels, a key acute‐phase reactant, were significantly lower in COPD patients compared with non‐COPD patients (44.12 ± 59.78 vs. 60.00 ± 61.82 mg/L, p < 0.001). The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.